Latest News about US0311621009
Recent news which mentions US0311621009
Amgen, BioMarin Lead Biotech Short Interest Trend (AMGN, BIIB, BMRN)
February 27, 2014
From Benzinga
France's Biosimilar Substitution May Lead to Erosion of Amgen
February 24, 2014
Tickers
AMGN
From Benzinga
Earnings Scheduled For January 28, 2014
January 27, 2014
From Benzinga
Benzinga Weekly Preview: Tech Sector To Steal The Spotlight
January 24, 2014
From Benzinga
Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-2 Trial Of Evolocumab (AMG 145) In Statin Intolerant Patients With High Cholesterol
January 23, 2014
Tickers
AMGN
From Benzinga
Market Wrap For January 16: Markets End Two Day Winning Streak
January 16, 2014
From Benzinga
From Benzinga
Amgen Announces Romosozumab Phase 2 Data Published In NEJM Show Significant Increases In Bone Mineral Density
January 01, 2014
From Benzinga
From Benzinga
UPDATE: Citigroup Reiterates on Amgen Following Detailed Market Analysis
December 06, 2013
Tickers
AMGN
From Benzinga
Goldman Sachs Comments on How Strong Sales of Kyprolis, Epogen, and Prolia Might Affect Amgen
November 29, 2013
Tickers
AMGN
From Benzinga
UPDATE: Piper Jaffray Initiates On Amgen On Series Of Bold Steps
November 27, 2013
Tickers
AMGN
From Benzinga
Celgene's Kyprolis Draws Focus Away From Amgen
November 22, 2013
From Benzinga
Annaly Capital, VIVUS And Others Insiders Have Been Buying
November 15, 2013
From Benzinga
Gilead Sciences Leads In Rising Short Interest Among Biotechs
November 12, 2013
From Benzinga
From Benzinga
Earnings Scheduled For October 22, 2013
October 21, 2013
From Benzinga
Earnings Expectations For The Week Of October 21: The Crunch Is On
October 20, 2013
From Benzinga
Amgen Announces Appointment Of Greg C. Garland To Board Of Directors
October 16, 2013
Tickers
AMGN
From Benzinga
Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)
October 11, 2013
From Benzinga
Biotech ETFs Plummeting (XBI, IBB, BBH)
October 08, 2013
From Benzinga
Amgen, AstraZeneca Highlight Brodalumab Data to be Presented at EADV
October 02, 2013
From Benzinga
Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
September 30, 2013
From Benzinga
US Stock Futures Signal Lower Start On Wall Street
September 30, 2013
From Benzinga
Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec
September 29, 2013
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.